Effects of vehicle and region of application on absorption of hydrocortisone through canine skin

American Journal of Veterinary Research

Volumn 66, Issue 1, 2005, Pages 43-47

  Mills, Paul C ^a   Magnusson, Beatrice M ^a   Cross, Sheree E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBON 14; DRUG RESIDUE; DRUG VEHICLE; HYDROCORTISONE; PROPYLENE GLYCOL; WATER;

ARTICLE; BATH; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG FORMULATION; DRUG RETENTION; DRUG TRANSPORT; INGUINAL REGION; ISOTOPE LABELING; NECK; NONHUMAN; SKIN PENETRATION; STORAGE TEMPERATURE; STRATUM CORNEUM; THAWING; THORAX;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DOGS; ETHANOL; HYDROCORTISONE; PROPYLENE GLYCOL; SKIN; SKIN ABSORPTION; SODIUM CHLORIDE; SOLUBILITY; VEHICLES;

CANIS FAMILIARIS;

EID: 13444273276     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.43     Document Type: Article

References (33)

1. Roberts MS, Cross SE, Pellett MA. Skin transport. In: Walters KA, ed. Dermatological and transdermal formulations. New York: Marcel Dekker Inc, 2002;89-196.
2. Finnin BC, Morgan TM. Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci 1999;88:955-958.
3. Lippold BC. How to optimize drug penetration through the skin. Pharm Acta Helv 1992;67:294-300.
4. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-114.
5. Australian prescription products guide. 31st ed. Hawthorn, Australia: Pharmaceutics Publishing Co Ltd, 2002.
6. Walters KA, Roberts MS. The structure and function of skin. In: Walters KA, ed. Dermatological and transdermal formulations. New York: Marcel Dekker Inc, 2002;1-40.
7. Monteiro-Riviere NA, Inman AO, Riviere JE, et al. Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature. Pharm Res 1993;10:1326-1331.
8. Magnusson BM, Koskinen LO, Koch M, et al. Biological effects after percutaneous absorption of thyrotropin-releasing hormone and its analogue M-TRH. Peptides 2001;22:73-79.
9. Tur E, Maibach HI, Guy RH. Percutancous penetration of methyl nicotinate at three anatomic sites: evidence for an appendageal contribution to transport? Skin Pharmacol 1991;4:230-234.
10. Hueber F, Schaefer H, Wepierre J. Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. Skin Pharmacol 1994;7:237-244.
11. Oriba HA, Bucks DA, Maibach HI. Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site. Br J Dermatol 1996;134:229-233.
12. Flynn GL, Durrheim H, Higuchi WI. Permeation of hairless mouse skin II: membrane sectioning techniques and influence on alkanol permeabilities. J Pharm Sci 1981;70:52-56.
13. Mills PC, Magnusson BM, Cross SE. The effect of region of application on absorption of ethanol and hexanol through canine skin. Res Vet Sci 2004;76:37-41.
14. Caron D, Queille-Roussel C, Shah VP, et al. Correlation between the drug penetration and the blanching effect of topically applied hydrocortisone creams in human beings. J Am Acad Dermatol 1990;23:458-462.
15. Hadgraft J. Recent developments in topical and transdermal delivery. Eur J Drug Metab Pharmacokinet 1996;21:165-173.
16. Qiao GL, Riviere JE. Significant effects of application site and occlusion on the pharmacokinetics of cutaneous penetration and biotransformation of parathion in vivo in swine. J Pharm Sci 1995;84:425-432.
17. Barry BW. Bioavailability of topical steroids. Dermatologica 1976;152(suppl 1):47-65.
18. Hueber F, Wepierre J, Schaefer H. Role of transepidermal and transfollicular routes in percutaneous absorption of hydrocortisone and testosterone: in vivo study in the hairless rat. Skin Pharmacol 1992;5:99-107.
19. Magnusson BM, Walters KA, Roberts MS. Veterinary drug delivery: potential for skin penetration enhancement. Adv Drug Deliv Rev 2001;50:205-227.
20. Schaefer H, Lademann J. The role of follicular penetration. A differential view. Skin Pharmacol Appl Skin Physiol 2001;14(suppl 1):23-27.
21. Monteiro-Riviere NA, Bristol DG, Manning TO, et al. Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species. J Invest Dermatol 1990;95:582-586.
22. Surber C, Wilhelm KP, Hori M, et al. Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharm Res 1990; 7:1320-1324.
23. Ayres PJ, Hooper G. Assessment of the skin penetration properties of different carrier vehicles for topically applied cortisol. Br J Dermatol 1978;99:307-317.
24. Hadgraft J, Whitefield M, Rosher PH. Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study. Skin Pharmacol Appl Skin Physiol 2003;16:137-142.
25. Walters KA, Brain K. Dermatological formulation and transdermal systems. In: Walters KA, ed. Dermatological and transdermal formulations. New York: Marcel Dekker Inc, 2002;319-399.
26. Kranz G, Schaefer H, Zesch A. Hydrocortisone (cortisol) concentration and penetration gradient. Acta Derm Venereol 1977;57:269-273.
27. Rosado C, Cross SE, Pugh WJ, et al. Effect of vehicle pretreatment on the flux, retention, and diffusion of topically applied penetrants in vitro. Pharm Res 2003;20:1502-1507.
28. Idson B. Vehicle effects in percutaneous absorption. Drug Metab Rev 1983;14:207-222.
29. Polano MK, Ponec M. Dependence of corticosteroid penetration on the vehicle. Arch Dermatol 1976;112:675-680.
30. Shahi V, Zatz JL. Effect of formulation factors on penetration of hydrocortisone through mouse skin. J Pharm Sci 1978;67:789-792.
31. Aungst BJ, Blake JA, Hussain MA. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm Res 1990;7:712-718.
32. Scheuplein RJ, Blank IH. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J Invest Dermatol 1973; 60:286-296.
33. Riviere JE, Papich MG. Potential and problems of developing Transdermal patches for veterinary applications. Adv Drug Deliv Rev 2001;50:175-203.